NEXENTIS TECHNOLOGIES INC. Common Stock, Value, Issued
NEXENTIS TECHNOLOGIES INC. (NXTS) had Common Stock, Value, Issued of $3.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2025-08-14
- 2025-06-30: Common Stock, Value, Issued $3.00K.
- 2025-03-31: Common Stock, Value, Issued $2.00K.
- 2024-12-31: Common Stock, Value, Issued $1.00K.
- 2024-09-30: Common Stock, Value, Issued $958.00.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2025-06-30 | $3.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.00K 10-Q · filed 2025-08-14 | |
| 2024-09-30 | $958.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $416.00 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $299.00 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $296.00 10-Q · filed 2024-11-14 | |
| 2023-09-30 | $146.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $777.00 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $466.00 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $69.00 10-K · filed 2024-04-01 | $462.00 10-K · filed 2023-03-27 |
| 2022-09-30 | $457.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $289.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $285.00 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $281.00 10-K · filed 2023-03-27 | |
| 2021-09-30 | $280.00 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $278.00 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $161.00 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $161.00 10-K · filed 2022-03-31 | |
| 2020-09-30 | $1.12K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.02K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $1.02K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $146.00 10-K · filed 2021-03-29 | $1.02K 10-K · filed 2020-03-30 |
| 2018-12-31 | $923.00 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |